May 22, 2023 07:40PM
Mar 2, 2023 10:14AM
Feb 7, 2023 04:02PM
Feb 7, 2023 04:01PM
Feb 6, 2023 08:00AM
Dec 7, 2022 02:30AM
Nov 20, 2022 08:46AM 6 biggest deal reports this week: Estee Lauder, Hasbro
Nov 14, 2022 02:12AM
Nov 14, 2022 02:10AM
Jul 24, 2020 10:35AM
Jun 24, 2020 08:30AM
Mar 23, 2020 08:00AM
Dec 10, 2019 09:30AM
Dec 2, 2019 08:00AM New Analysis From One-Year Study of Monthly Buprenorphine Extended-Release Injections Showed Improved or Stable Patient-Centered Outcomes
Nov 11, 2019 12:43PM
Sep 26, 2019 03:19PM
Jun 17, 2019 02:43PM
Apr 9, 2019 06:01PM
Apr 6, 2019 08:36AM
Apr 5, 2019 08:36AM
Mar 7, 2019 10:30AM The Journal of Addiction Medicine Publishes Patient-centered Outcomes from the Phase 3 Study of SUBLOCADE™ (Buprenorphine Extended-Release) Injection in Patients with Moderate to Severe Opioid Use D
Feb 27, 2019 08:06AM
Feb 20, 2019 09:37AM
Feb 19, 2019 08:00AM
Dec 20, 2018 09:00AM
Nov 27, 2018 08:00AM
Nov 23, 2018 09:56AM
Nov 21, 2018 09:30AM Court of Appeals for the Federal Circuit Lifts Preliminary Injunction on Generic (buprenorphine and naloxone) Sublingual Film
Nov 19, 2018 08:06AM
Nov 1, 2018 07:26AM
Oct 24, 2018 02:32PM
Sep 26, 2018 11:57AM
Jul 31, 2018 08:03AM
Jul 27, 2018 07:44PM
Jul 13, 2018 06:22PM Indivior Is Granted Preliminary Injunction on Generic (buprenorphine and naloxone) Sublingual Film
Jul 11, 2018 07:47AM
Jun 28, 2018 06:07PM
Jun 15, 2018 08:00PM
Jun 15, 2018 10:11AM
May 31, 2018 08:45AM
May 25, 2018 09:55AM
Apr 20, 2018 09:00AM Indivior Announces New Drug Submission to Health Canada for SUBLOCADE™ (Buprenorphine Extended-Release) Injection for the Treatment of Moderate to Severe Opioid Use Disorder
Apr 13, 2018 11:44AM
Mar 29, 2018 08:00AM
Mar 1, 2018 08:00AM
Jan 3, 2018 08:00AM
Nov 30, 2017 08:52PM
Oct 31, 2017 04:58PM
Jul 31, 2017 08:30AM Indivior PLC Announces FDA Acceptance with Priority Review Designation of RBP-6000 Buprenorphine Monthly Depot New Drug Application (NDA) for the Treatment of Opioid Use Disorder
Jun 21, 2017 12:24PM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All